Jim Cramer Discusses Value in CVS and Micron's Strong Quarter
Jim Cramer Highlights CVS Health's Potential
On a recent episode of CNBC's 'Mad Money Lightning Round,' Jim Cramer shared his positive outlook on CVS Health Corporation (NYSE: CVS). Cramer emphasized, “I think there’s real value here,” indicating that investors should consider CVS as a viable opportunity in the current market.
Recent Analyst Upgrades
Supporting Cramer's sentiments, analyst Andrew Mok from Barclays upgraded CVS Health from Equal-Weight to Overweight and raised the price target from $63 to $82. Such positive analyst attention could signal to investors that CVS might be on an upward trajectory.
Micron Technology's Stellar Performance
Cramer also expressed enthusiasm for Micron Technology, Inc. (NASDAQ: MU), stating it had an “amazing” quarter. This positive remark reflects a growing confidence in Micron's ability to deliver strong financial results in a competitive industry.
Price Target Adjustments
Following this, analyst John Vinh from Keybanc maintained an Overweight rating on Micron but adjusted the price target downward from $145 to $135. This suggests varying opinions within the analyst community, yet Cramer’s recommendation may encourage investors to weigh their options.
Other Stocks on Cramer's Radar
In addition to CVS and Micron, Cramer mentioned his preference for stocks in various sectors. He expects strong performance from Old Dominion Freight Line (NASDAQ: ODFL) but prefers the stock of Union Pacific (NYSE: UNP), indicating his broader view on the transportation industry.
Stock Ratings and Insights
Analyst Ariel Rosa from Citigroup initiated coverage on Old Dominion Freight Line with a Neutral rating and set a price target of $206. Cramer's insights, mixed with these analyst ratings, provide a comprehensive view for investors considering the freight sector.
Concerns about Certain Stocks
Cramer has also cautioned against investing in certain stocks, notably American Tower (NYSE: AMT). Despite recent upgrades by analysts like Tim Long from Barclays, who raised the price target from $223 to $255, Cramer is advising caution in this area.
Additional Recommendations
On the other hand, Cramer spoke positively about Howmet Aerospace Inc (NYSE: HWM), predicting it will see further growth. He referred to it as one of the standout stocks of his time, which hints at the company's strong fundamentals.
Investment Viability of Other Companies
Moving on, Cramer categorized ADMA Biologics (NASDAQ: ADMA) as a “very speculative” investment. Analyst Kristen Kluska from Cantor Fitzgerald reiterated an Overweight rating but maintained a risky $20 price target due to the volatility in this sector.
Insights into Manufacturing Stocks
Cramer also highlighted Modine Manufacturing (NYSE: MOD), calling it a great metal-bending company. Analyst Matt Summerville from DA Davidson showed confidence by maintaining a Buy rating and raising the price target from $140 to $155, which may attract investor interest.
Market Reactions and Stock Movements
The market showed varied reactions to these comments. For instance, shares of Old Dominion gained 0.1% to settle at $194.59, while Micron surged by 3.9%, closing at $105.69. In contrast, American Tower fell by 1.3% to $217.90. These changes highlight the volatility and the potential impact of analyst ratings and expert opinions on stock prices.
Investor Feedback
Cramer's commentary on stocks like Robinhood (NASDAQ: HOOD), which he considers a buy, reflects his ongoing confidence in tech investments. Following a maintenance of Overweight status from analyst Patrick Moley, Robinhood closed at $25.50, despite a slight decline of 0.6%.
Frequently Asked Questions
What did Jim Cramer say about CVS Health?
Cramer highlighted the potential value in CVS Health, suggesting it is a worthwhile investment opportunity.
How did Micron Technology perform recently?
Cramer called Micron's recent quarter amazing, indicating strong financial performance.
What is Cramer's view on American Tower?
Cramer advised against investing in American Tower, despite analyst upgrades, indicating caution for potential investors.
Which stocks did Cramer recommend for investors?
Cramer recommended CVS, Micron, Modine Manufacturing, and Howmet Aerospace as strong investments.
What are the recent price movements for these stocks?
CVS shares gained 1.3%, while other stocks showed slight variations, highlighting the mixed performance influenced by market sentiment.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Innovative Student Entrepreneur Wins National Challenge in NYC
- Festi hf. Welcomes New Managing Director to Executive Team
- Tevogen Bio Advances Cancer Treatments with Innovative Technology
- Understanding the Class Action Against Super Micro Computer Inc.
- Universal Robots Advances Cobot Welding Technology for All
- Emerging Threat: The Rise of Counterfeit Weight Loss Drugs
- Top Wealth Group Surges Following Public Offering Announcement
- Alliant Energy's Q3 2024 Earnings Release and Conference Call Details
- Discovering the Growth of Blackstone Investments Over Time
- Jacquet Metals SA's Latest Shareholder Update and Insights
Recent Articles
- Can Truth+ Streaming App Boost Trump Media's Stock Further?
- Pelorus Fund REIT Backs Bankruptcy Filing for StateHouse Holdings
- Alignment Credit Supports Riverview Companies with Loan
- Sanofi Explores $16 Billion Deal to Expand Consumer Healthcare Unit
- Embracing AI in Low-Code Development: A New Era
- SONiC Community Welcomes New Members and Expands Influence
- DataTracks Enhances Shareholder Reporting with Cutting-Edge Automation
- Brazilian President Challenges U.S. Request on Fighter Jets Deal
- Cassidy Reid Begins a New Chapter with Inspiring Sound
- Mandalay Resources Maintains Outperform Rating by BMO Capital
- Standard Textile Triumphs with Award-Winning Innovations
- Uber Technologies Inc. Confident Amid Tesla Cyber Cab Plans
- Race Communications Launches Fiber Internet in New Area
- Middleby's Strategic Acquisition of Emery Thompson for Growth
- Empowering Girls Through Digital Wellness Education Initiative
- Darden Restaurants Strengthens Portfolio with Chuy's Acquisition
- Duke Energy Florida Initiates Hurricane Recovery Efforts
- CN Energy Reclaims Nasdaq Compliance Amid Financial Challenges
- Big Ass Fans Launches Cody Dorman Legacy Fund for Wishes
- HubSpot Expands Commerce with Cacheflow Acquisition Strategy
- Exploring the Enduring Legacy of Yogi Berra Beyond Baseball
- Anita Chang Returns as COO at Tigo Energy Amid Changes
- Lowe's Expands Support with $10 Million Hurricane Relief Fund
- Mizuho Keeps Neutral Rating on ConocoPhillips Amid EPS Challenges
- Citi Boosts GXO Target as Company Explores Acquisition Options
- Samsara's Stock Upgrade Signals Strong Growth Ahead for Investors
- Italy's Economic Outlook: Growth Forecasts and Inflation Trends
- Positive Outlook for Atlassian as Morgan Stanley Upgrades Stock
- China's Beauty Market Faces Unprecedented Challenges: A Deep Dive
- VARTA AG Adjusts 2024 Revenue Forecast Due to Market Challenges
- Beyond Yoga Unveils Club Beyond: A Unique NYC Experience
- Celebrating Girls' Empowerment Through Pace Center Initiatives
- Explore Ethernovia's Innovations at 2024 Automotive Technology Day
- Exploring the Rapid Growth of Speech Analytics Market
- Dong-A ST Celebrates FDA Approval of Imuldosa™ Biosimilar
- Beazer Homes Celebrates 30 Years on NYSE, Promoting Energy Efficiency
- Global Cybersecurity Market Surge with Advanced Solutions
- SqlSafeKeep Launches on Microsoft Azure Marketplace for Users
- Chitosan Market Forecast: Reaching USD 101 Billion Soon
- Armexa’s John Cusimano to Share Insights at Cybersecurity Event
- Projected Growth of Lawn Mowers Market to US$ 51.28 Billion
- NUBURU Transitions to Enhanced Equity Line of Credit
- Recognition of Diversity: Ye Jane Li Named NACD Honoree 2024
- Capricor Therapeutics Shares Breakthrough Findings on Deramiocel
- Tigo Energy Welcomes Anita Chang Back as COO to Drive Growth
- Explore Firefly Neuroscience's October Investor Engagements
- Amplitude's Upcoming Earnings Webcast and Insights into Growth
- Abacus Life Set to Reveal Third Quarter Earnings Details Soon
- Protolabs Announces Third Quarter 2024 Financial Call Details
- Nutanix Achieves Leader Status in Gartner's 2024 Magic Quadrant